Skip to main content
PMC home page
Heart logoLink to Heart
. 2001 Oct;86(4):459–466. doi: 10.1136/heart.86.4.459

Cardiovascular complications of renal disease

A Jardine 1, K McLaughlin 1
PMCID: PMC1729948  PMID: 11559693

Full Text

The Full Text of this article is available as a PDF (170.1 KB).

Figure 1:  .

Figure 1:  

Open in a new tab

Phases of progressive renal disease with estimates of cardiovascular disease risk compared with the general population. CRF, chronic renal failure; RRT, renal replacement therapy; Tx, transplantation.

Figure 2:  .

Figure 2:  

Figure 2:  

Open in a new tab

Calcified vessels and valves. Atherosclerosis in progressive renal disease has features that suggest conventional interventions may be ineffective. These panels show calcification of digital vessels in a patient with end stage renal failure, and a calcified valvar lesion.

Figure 3:  .

Figure 3:  

Open in a new tab

Data from the US Renal Disease Service (USRDS) showing CVD mortality rates in patients on renal replacement therapy compared with normal background population. The most dramatic relative increase is seen in the youngest patients on dialysis programmes.3

Figure 4:  .

Figure 4:  

Open in a new tab

Kaplan-Meier survival curves from patients receiving cadaveric transplants at the Western Infirmary, Glasgow. Comparison of patients with continuing graft function and all transplants including graft failures.6

Figure 5:  .

Figure 5:  

Open in a new tab

Comparison of magnetic resonance (MR) (x axis) and echocardiographic (y axis) estimates of left ventricular mass index (LVMI) in haemodialysis patients. Because of the dependence of echocardiographic estimates of left ventricular mass on chamber diameter, echocardiography progressively overestimates left ventricular mass with increasing mass.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baigent C., Burbury K., Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000 Jul 8;356(9224):147–152. doi: 10.1016/S0140-6736(00)02456-9. [DOI] [PubMed] [Google Scholar]
  2. Block G. A., Hulbert-Shearon T. E., Levin N. W., Port F. K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998 Apr;31(4):607–617. doi: 10.1053/ajkd.1998.v31.pm9531176. [DOI] [PubMed] [Google Scholar]
  3. Charra B., Calemard M., Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol. 1996;16(1):35–44. doi: 10.1159/000168968. [DOI] [PubMed] [Google Scholar]
  4. Foley R. N., Parfrey P. S., Harnett J. D., Kent G. M., Martin C. J., Murray D. C., Barre P. E. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995 Jan;47(1):186–192. doi: 10.1038/ki.1995.22. [DOI] [PubMed] [Google Scholar]
  5. Foley R. N., Parfrey P. S., Sarnak M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S112–S119. doi: 10.1053/ajkd.1998.v32.pm9820470. [DOI] [PubMed] [Google Scholar]
  6. Goodman W. G., Goldin J., Kuizon B. D., Yoon C., Gales B., Sider D., Wang Y., Chung J., Emerick A., Greaser L. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000 May 18;342(20):1478–1483. doi: 10.1056/NEJM200005183422003. [DOI] [PubMed] [Google Scholar]
  7. Goodman W. G., Goldin J., Kuizon B. D., Yoon C., Gales B., Sider D., Wang Y., Chung J., Emerick A., Greaser L. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000 May 18;342(20):1478–1483. doi: 10.1056/NEJM200005183422003. [DOI] [PubMed] [Google Scholar]
  8. Herzog C. A., Ma J. Z., Collins A. J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998 Sep 17;339(12):799–805. doi: 10.1056/NEJM199809173391203. [DOI] [PubMed] [Google Scholar]
  9. Ibels L. S., Alfrey A. C., Huffer W. E., Craswell P. W., Anderson J. T., Weil R., 3rd Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med. 1979 May;66(5):790–796. doi: 10.1016/0002-9343(79)91118-5. [DOI] [PubMed] [Google Scholar]
  10. Jardine A., Holdaas H. Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience. J Clin Pharm Ther. 1999 Dec;24(6):397–408. doi: 10.1046/j.1365-2710.1999.00252.x. [DOI] [PubMed] [Google Scholar]
  11. Jindal R. M., Hjelmesaeth J. Impact and management of posttransplant diabetes mellitus. Transplantation. 2000 Dec 15;70(11 Suppl):SS58–SS63. [PubMed] [Google Scholar]
  12. Kasiske B. L., Chakkera H. A., Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol. 2000 Sep;11(9):1735–1743. doi: 10.1681/ASN.V1191735. [DOI] [PubMed] [Google Scholar]
  13. Le Feuvre C., Dambrin G., Helft G., Beygui F., Touam M., Grünfeld J. P., Vacheron A., Metzger J. P. Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting. Heart. 2001 May;85(5):556–560. doi: 10.1136/heart.85.5.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Levin A., Thompson C. R., Ethier J., Carlisle E. J., Tobe S., Mendelssohn D., Burgess E., Jindal K., Barrett B., Singer J. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999 Jul;34(1):125–134. doi: 10.1016/s0272-6386(99)70118-6. [DOI] [PubMed] [Google Scholar]
  15. Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993 Nov 11;329(20):1456–1462. doi: 10.1056/NEJM199311113292004. [DOI] [PubMed] [Google Scholar]
  16. Liu J. Y., Birkmeyer N. J., Sanders J. H., Morton J. R., Henriques H. F., Lahey S. J., Dow R. W., Maloney C., DiScipio A. W., Clough R. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 2000 Dec 12;102(24):2973–2977. doi: 10.1161/01.cir.102.24.2973. [DOI] [PubMed] [Google Scholar]
  17. Marso S. P., Gimple L. W., Philbrick J. T., DiMarco J. P. Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis. Am J Cardiol. 1998 Aug 1;82(3):378–380. doi: 10.1016/s0002-9149(98)00347-6. [DOI] [PubMed] [Google Scholar]
  18. McLaughlin K., Jardine A. G. Clinical management of diabetic nephropathy. Diabetes Obes Metab. 1999 Nov;1(6):307–315. doi: 10.1046/j.1463-1326.1999.00041.x. [DOI] [PubMed] [Google Scholar]
  19. Morris S. T., Galiatsou E., Stewart G. A., Rodger R. S., Jardine A. G. QT dispersion before and after hemodialysis. J Am Soc Nephrol. 1999 Jan;10(1):160–163. doi: 10.1681/ASN.V101160. [DOI] [PubMed] [Google Scholar]
  20. Opelz G., Wujciak T., Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int. 1998 Jan;53(1):217–222. doi: 10.1046/j.1523-1755.1998.00744.x. [DOI] [PubMed] [Google Scholar]
  21. Parfrey P. S., Foley R. N., Harnett J. D., Kent G. M., Murray D. C., Barre P. E. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996 Jul;11(7):1277–1285. [PubMed] [Google Scholar]
  22. Rinehart A. L., Herzog C. A., Collins A. J., Flack J. M., Ma J. Z., Opsahl J. A. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis. 1995 Feb;25(2):281–290. doi: 10.1016/0272-6386(95)90010-1. [DOI] [PubMed] [Google Scholar]
  23. Schillaci G., Reboldi G., Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med. 2001 Mar 26;161(6):886–891. doi: 10.1001/archinte.161.6.886. [DOI] [PubMed] [Google Scholar]
  24. Schwarz U., Buzello M., Ritz E., Stein G., Raabe G., Wiest G., Mall G., Amann K. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000 Feb;15(2):218–223. doi: 10.1093/ndt/15.2.218. [DOI] [PubMed] [Google Scholar]
  25. Stewart G. A., Foster J., Cowan M., Rooney E., McDonagh T., Dargie H. J., Rodger R. S., Jardine A. G. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int. 1999 Dec;56(6):2248–2253. doi: 10.1046/j.1523-1755.1999.00786.x. [DOI] [PubMed] [Google Scholar]
  26. Woo Y. M., Jardine A. G., Clark A. F., MacGregor M. S., Bowman A. W., Macpherson S. G., Briggs J. D., Junor B. J., McMillan M. A., Rodger R. S. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int. 1999 Feb;55(2):692–699. doi: 10.1046/j.1523-1755.1999.00294.x. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES